BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31531916)

  • 1. Exosomes and Nanoengineering: A Match Made for Precision Therapeutics.
    Tran PHL; Xiang D; Tran TTD; Yin W; Zhang Y; Kong L; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Duan W
    Adv Mater; 2020 May; 32(18):e1904040. PubMed ID: 31531916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post isolation modification of exosomes for nanomedicine applications.
    Hood JL
    Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.
    Zhu Q; Heon M; Zhao Z; He M
    Lab Chip; 2018 Jun; 18(12):1690-1703. PubMed ID: 29780982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-Exosomes for Tumor Theranostics.
    Yi K; Rong Y; Huang L; Tang X; Zhang Q; Wang W; Wu J; Wang F
    ACS Sens; 2021 Apr; 6(4):1418-1429. PubMed ID: 33755415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-guided extracellular vesicle theranostics in oncology.
    Tran PH; Xiang D; Nguyen TN; Tran TT; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W
    Theranostics; 2020; 10(9):3849-3866. PubMed ID: 32226524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.
    Sunderland KS; Yang M; Mao C
    Angew Chem Int Ed Engl; 2017 Feb; 56(8):1964-1992. PubMed ID: 27491926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
    Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
    Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine.
    Mittal R; Jhaveri VM; McMurry HS; Kay SS; Sutherland KJ; Nicole L; Mittal J; Jayant RD
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):831-840. PubMed ID: 29447002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible exosomes nanodrug cargo for cancer cell bioimaging and drug delivery.
    Qambrani A; Rehman FU; Tanziela T; Shaikh S; Semcheddine F; Du T; Liu W; Jiang H; Wang X
    Biomed Mater; 2021 Feb; 16(2):025026. PubMed ID: 32726764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
    Zheng Y; Li M; Weng B; Mao H; Zhao J
    Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial exosomes for translational nanomedicine.
    Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
    J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes.
    Choi H; Choi Y; Yim HY; Mirzaaghasi A; Yoo JK; Choi C
    Tissue Eng Regen Med; 2021 Aug; 18(4):499-511. PubMed ID: 34260047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic approach to exosome-based translational nanomedicine.
    Hood JL; Wickline SA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):458-67. PubMed ID: 22648975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue.
    Li Q; Fu X; Kou Y; Han N
    Theranostics; 2023; 13(12):4266-4286. PubMed ID: 37554270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.